Anthony Chan, Li Shu Fan Medical Foundation Professor of Clinical Oncology, graduated from University College London in 1988 and received postgraduate training in the United Kingdom including the Royal Marsden Hospital where he developed a keen interest in multi-disciplinary clinical and translational research in solid cancers. He joined the Chinese University of Hong Kong in 1993 as Lecturer, becoming Department Chairman in 2002 and Professor of Clinical Oncology in 2006. He has been appointed Director of the Hong Kong Cancer Institute since 2002, Director of the Sir Yue-KongPao Centre for Cancer since 2003, Associate Director of the State Key Laboratory of Oncology in South China since 2006, Associate Dean for External Affairs since 2009, Chief Director of Phase I Clinical Trial Centre since 2013. He is Vice-President of the Hong Kong College of Physicians. His research has focused on clinical and translational studies in Asia-prevalent cancers, particularly in nasopharynx cancer. Professor Chan has conducted pivotal studies in multimodality treatment approaches in nasopharynx cancer, developed the clinical application of the biomarker EBV DNA and pioneered immunotherapeutic and targeted therapeutics in this disease. He published over 230 peer-reviewed papers, 40 book chapters, and reviews, and delivered over 130 international lectures. He has served on the Editorial Board of the Journal of Clinical Oncology and is currently on the Editorial Boards of International Journal of Cancer, Cancer Science, Oral Oncology and the Chinese Journal of Cancer. He is Faculty member of Oncology, F1000Prime. In January 2014, he will serve as Associate Editor for Annals of Oncology.

 Oncology